These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

424 related items for PubMed ID: 2916833

  • 1. Expression of monoclonal antibody-defined tumor markers in four carcinomas.
    Wu JT.
    Ann Clin Lab Sci; 1989; 19(1):17-26. PubMed ID: 2916833
    [Abstract] [Full Text] [Related]

  • 2. [Clinical evaluation of the tumor marker CA 19-9 in comparison with carcinoembryonic antigen (CEA) in surgical pre- and postoperative diagnosis].
    Lorenz M, Happ J, Hottenrott C, Maul FD, Baum RP, Hör G, Encke A.
    Nuklearmedizin; 1986 Feb; 25(1):9-14. PubMed ID: 3459133
    [Abstract] [Full Text] [Related]

  • 3. A comparative study of mucin-like carcinoma-associated antigen (MCA), CA 125, CA 19-9 and CEA in patients with ovarian cancer.
    Koelbl H, Schieder K, Neunteufel W, Bieglmayer C.
    Neoplasma; 1989 Feb; 36(4):473-8. PubMed ID: 2770933
    [Abstract] [Full Text] [Related]

  • 4. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R, Kiefe C, Rose E, Sutton F, Brown J, Alpert E.
    Cancer Res; 1993 Jun 15; 53(12):2803-9. PubMed ID: 7684947
    [Abstract] [Full Text] [Related]

  • 5. [Place of carbohydrate antigens in the spectrum of protein tumor markers in patients with tumors at different sites].
    Reznikov IuP, Ul'ianov VI, Variukhin AS, Vanin AI, Vorontsova LP.
    Vopr Onkol; 1988 Jun 15; 34(1):51-6. PubMed ID: 3422524
    [Abstract] [Full Text] [Related]

  • 6. [Comparison of the tumor markers CEA and CA 19-9 in colorectal diagnosis].
    Heptner G, Domschke S, Krapf F, Schneider MU, Iro H, Domschke W.
    Dtsch Med Wochenschr; 1984 Aug 31; 109(35):1309-12. PubMed ID: 6590287
    [Abstract] [Full Text] [Related]

  • 7. [Sensitivity and specificity of CEA, Ca 15-3 and MCA levels in visceral breast carcinoma metastasis].
    Delbrück H, Hagen-Aukamp C, Braun G.
    Strahlenther Onkol; 1990 Jul 31; 166(7):457-9. PubMed ID: 2200152
    [Abstract] [Full Text] [Related]

  • 8. [CA 15-3 is present as a novel tumor marker in the sera of patients with breast cancer and other malignancies].
    Gang Y, Adachi I, Ohkura H, Yamamoto H, Mizuguchi Y, Abe K.
    Gan To Kagaku Ryoho; 1985 Dec 31; 12(12):2379-86. PubMed ID: 3865634
    [Abstract] [Full Text] [Related]

  • 9. Relative operating characteristic analysis and group modeling for tumor markers: comparison of CA 15.3, carcinoembryonic antigen, and mucin-like carcinoma-associated antigen in breast carcinoma.
    Silver HK, Archibald BL, Ragaz J, Coldman AJ.
    Cancer Res; 1991 Apr 01; 51(7):1904-9. PubMed ID: 2004374
    [Abstract] [Full Text] [Related]

  • 10. [Comparative study of the role of CA 19-9, CA 72-4 and CEA tumor antigens in the diagnosis of pancreatic cancer and other gastrointestinal malignant diseases].
    Czakó L, Takács T, Babarczy E, Dux L, Lonovics J.
    Orv Hetil; 1997 Nov 23; 138(47):2981-5. PubMed ID: 9432648
    [Abstract] [Full Text] [Related]

  • 11. [Antigens associated with cancer of the pancreas].
    Burtin P.
    Bull Cancer; 1990 Nov 23; 77(1):69-73. PubMed ID: 2317577
    [Abstract] [Full Text] [Related]

  • 12. [Tumor markers in gynecologic diseases].
    Geyer H, Kleine W.
    Geburtshilfe Frauenheilkd; 1987 Mar 23; 47(3):168-72. PubMed ID: 3472991
    [Abstract] [Full Text] [Related]

  • 13. [Value and limitations of neoplasm markers in the diagnosis of pancreatic carcinoma].
    Fabris C, Basso D, Meggiato T, Del Favero G, Fogar P, Panozzo MP, Ferrara C, Scalon P, Naccarato R.
    Recenti Prog Med; 1991 Mar 23; 82(3):166-72. PubMed ID: 2047559
    [Abstract] [Full Text] [Related]

  • 14. Comparative evaluation of four tumor markers, CA 242, CA 19/9, TPA and CEA in carcinomas of the colon.
    von Kleist S, Hesse Y, Kananeeh H.
    Anticancer Res; 1996 Mar 23; 16(4B):2325-31. PubMed ID: 8694564
    [Abstract] [Full Text] [Related]

  • 15. The clinical relevance of the tumor marker CA 19-9 in the diagnosing and monitoring of pancreatic carcinoma.
    Safi F, Roscher R, Beger HG.
    Bull Cancer; 1990 Mar 23; 77(1):83-91. PubMed ID: 2180502
    [Abstract] [Full Text] [Related]

  • 16. Detection of blood-borne cells in colorectal cancer patients by nested reverse transcription-polymerase chain reaction for carcinoembryonic antigen messenger RNA: longitudinal analyses and demonstration of its potential importance as an adjunct to multiple serum markers.
    Guadagni F, Kantor J, Aloe S, Carone MD, Spila A, D'Alessandro R, Abbolito MR, Cosimelli M, Graziano F, Carboni F, Carlini S, Perri P, Sciarretta F, Greiner JW, Kashmiri SV, Steinberg SM, Roselli M, Schlom J.
    Cancer Res; 2001 Mar 15; 61(6):2523-32. PubMed ID: 11289125
    [Abstract] [Full Text] [Related]

  • 17. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S, Mroczko B, Szmitkowski M.
    Postepy Hig Med Dosw; 2002 Mar 15; 56(5):617-34. PubMed ID: 12596691
    [Abstract] [Full Text] [Related]

  • 18. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
    Wu JT, Miya T, Knight JA, Knight DP.
    Clin Chem; 1988 Sep 15; 34(9):1853-7. PubMed ID: 2458203
    [Abstract] [Full Text] [Related]

  • 19. Comparison of portal and peripheral blood levels of carcinoembryonic antigen, CA 19-9, and CA 125 tumor-associated antigens in patients with colorectal and pancreatic cancer.
    Talbot RW, Nagorney DM, Pemberton JH, Wieand HS, Ritts RE.
    Cancer Res; 1989 Feb 01; 49(3):542-3. PubMed ID: 2910474
    [Abstract] [Full Text] [Related]

  • 20. Tumour markers in pancreatic cancer.
    Haglund C, Kuusela P, Roberts PJ.
    Ann Chir Gynaecol; 1989 Feb 01; 78(1):41-53. PubMed ID: 2667448
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.